These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 1506155

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inferior vena cava tumor thrombus: demonstration by Gd-DTPA enhanced MR.
    Gehl HB, Bohndorf K, Klose KC.
    J Comput Assist Tomogr; 1990; 14(3):479-81. PubMed ID: 2335623
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Organ and tissue specific contrast media in magnetic resonance imaging.
    Niemi P.
    Acta Radiol Suppl; 1991; 377():56-7. PubMed ID: 1666259
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Review of the use of high-dose gadoteridol in the magnetic resonance evaluation of central nervous system tumors.
    Yuh WT, Fisher DJ, Mayr-Yuh NA, Tali ET, Nguyen HD, Gao F, Ehrhardt JC.
    Invest Radiol; 1992 Aug; 27 Suppl 1():S39-44. PubMed ID: 1506152
    [No Abstract] [Full Text] [Related]

  • 30. Current status of MR imaging contrast agents: special report.
    Wolf GL.
    Radiology; 1989 Sep; 172(3):709-10. PubMed ID: 2672095
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide.
    Chang CA.
    Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pitfalls of contrast-enhanced imaging in the nervous system.
    Brant-Zawadzki M.
    Magn Reson Med; 1991 Dec; 22(2):243-8. PubMed ID: 1812353
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Contrast-enhanced MR imaging of neurocutaneous melanosis.
    Rhodes RE, Friedman HS, Hatten HP, Hockenberger B, Oakes WJ, Tomita T.
    AJNR Am J Neuroradiol; 1991 Dec; 12(2):380-2. PubMed ID: 1902050
    [No Abstract] [Full Text] [Related]

  • 38. Paramagnetic dextrans as magnetic resonance contrast agents.
    Meyer D, Schaefer M, Bouillot A, Beauté S, Chambon C.
    Invest Radiol; 1991 Nov; 26 Suppl 1():S50-2; discussion S60-4. PubMed ID: 1725521
    [No Abstract] [Full Text] [Related]

  • 39. Interactions of paramagnetic contrast agents and the spin echo pulse sequence.
    Joseph PM.
    Invest Radiol; 1989 Jun; 24(6):508-9. PubMed ID: 2562496
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.